Healthy Volunteers, Pulmonary Arterial Hypertension

Cardiovascular·MeSH: Pulmonary Arterial Hypertension

Prevalence

5.0 / 100K

2 drugs in development·2 companies·1 clinical trial

Drug Pipeline by Phase

Phase 1/Phase 2(2)
DrugCompany
ltpNovartis AG (NVS)
ltpNOVARTIS AG (NVSEF)

Frequently asked questions

How many drugs are in development for Healthy Volunteers, Pulmonary Arterial Hypertension?

BioSniper tracks 2 drugs in development for Healthy Volunteers, Pulmonary Arterial Hypertension across 2 companies.

How many clinical trials target Healthy Volunteers, Pulmonary Arterial Hypertension?

There are 1 clinical trial targeting Healthy Volunteers, Pulmonary Arterial Hypertension tracked by BioSniper.

What is the prevalence of Healthy Volunteers, Pulmonary Arterial Hypertension?

The estimated prevalence of Healthy Volunteers, Pulmonary Arterial Hypertension is approximately 5.0 per 100,000 population.

Deep-dive into Healthy Volunteers, Pulmonary Arterial Hypertension

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Healthy Volunteers, Pulmonary Arterial Hypertension — Drugs in Development & Clinical Trials | BioSniper